<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
  <title>MicroCap Desk</title>
  <link>https://microcapdesk.com/</link>
  <description>Daily reporting on the overlooked end of the U.S. equity market.</description>
  <language>en-us</language>
  <copyright>Copyright 2026 MicroCap Desk</copyright>
  <lastBuildDate>Sat, 18 Apr 2026 14:28:03 +0000</lastBuildDate>
  <ttl>60</ttl>
  <atom:link href="https://microcapdesk.com/feed.xml" rel="self" type="application/rss+xml" />
  <image>
    <url>https://microcapdesk.com/images/homepage/hero-feature.jpg</url>
    <title>MicroCap Desk</title>
    <link>https://microcapdesk.com/</link>
  </image>
  <item>
    <title>Corbus aligns with FDA on pivotal path for CRB-701</title>
    <link>https://microcapdesk.com/articles/corbus-pharmaceuticals-adc-pipeline-readout.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/corbus-pharmaceuticals-adc-pipeline-readout.html</guid>
    <pubDate>Fri, 17 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Biotech</category>
    <description>Corbus Pharmaceuticals (CRBP) secured written FDA alignment on the registrational endpoint for nectin-4 ADC CRB-701. Catalyst calendar compresses by 6–12 months. Balance sheet analysis and three scenarios.</description>
  </item>
  <item>
    <title>Palladyne AI&#x27;s Air Force HANGTIME contract is the proof point the thesis needed</title>
    <link>https://microcapdesk.com/articles/palladyne-ai-foundation-models-robotics.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/palladyne-ai-foundation-models-robotics.html</guid>
    <pubDate>Fri, 17 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Tech</category>
    <description>Palladyne AI (PDYN) secured a named, dollar-valued Air Force AFWERX award for counter-UAS autonomy under the HANGTIME program. For a pre-revenue robotics platform, this is the category of catalyst that moves institutional ownership.</description>
  </item>
  <item>
    <title>The Innodata pullback is telling you something the revenue number isn&#x27;t</title>
    <link>https://microcapdesk.com/articles/innodata-ai-training-data-revenue-growth.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/innodata-ai-training-data-revenue-growth.html</guid>
    <pubDate>Thu, 16 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Tech</category>
    <description>Innodata (INOD) trades ~30% off despite top-line growth. The pullback is the market pricing in a narrowing of the AI-data-services premium. Customer concentration is the key slide.</description>
  </item>
  <item>
    <title>Three years of durable vision in the MeiraGTx long-term follow-up</title>
    <link>https://microcapdesk.com/articles/meiragtx-aav-gene-therapy-pipeline.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/meiragtx-aav-gene-therapy-pipeline.html</guid>
    <pubDate>Thu, 16 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Biotech</category>
    <description>MeiraGTx (MGTX) extended Phase 1/2 AAV5-RPGR follow-up to 36 months at ARVO with no meaningful acuity drop-off. Durability confirmed — the rerating thesis needs more than one asset.</description>
  </item>
  <item>
    <title>Soluna closes Dorothy 1A, sets up the Project Kati monetization story</title>
    <link>https://microcapdesk.com/articles/soluna-dorothy-1a-acquisition-project-kati.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/soluna-dorothy-1a-acquisition-project-kati.html</guid>
    <pubDate>Thu, 16 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Energy</category>
    <description>Soluna Holdings (SLNH) closes $16.5M Dorothy 1A acquisition from Spring Lane Capital, completing Texas stack ownership. The next question is what hyperscaler monetization looks like.</description>
  </item>
  <item>
    <title>Clearmind&#x27;s AUD Phase 1/2a hits its primary — with a catch</title>
    <link>https://microcapdesk.com/articles/clearmind-medicine-psychedelic-trial-readout.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/clearmind-medicine-psychedelic-trial-readout.html</guid>
    <pubDate>Wed, 15 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Biotech</category>
    <description>Clearmind Medicine (CMND) reports CMND-100 met its primary biomarker endpoint in the first Phase 1/2a cohort for alcohol use disorder. Mechanism is the bull case. Cash and comparables are the catches.</description>
  </item>
  <item>
    <title>Datavault rebrands toward quantum. The financials tell a different story</title>
    <link>https://microcapdesk.com/articles/datavault-data-monetization-platform-thesis.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/datavault-data-monetization-platform-thesis.html</guid>
    <pubDate>Wed, 15 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Tech</category>
    <description>Datavault AI (DVLT) has positioned itself from AI data vault to HPC and quantum in less than a year. The press releases describe a platform company. The filings describe a pre-revenue small-cap with accumulating share count.</description>
  </item>
  <item>
    <title>Northrim BanCorp: Alaska&#x27;s community bank printing EPS growth against the cycle</title>
    <link>https://microcapdesk.com/articles/northrim-bancorp-alaska-energy-exposure.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/northrim-bancorp-alaska-energy-exposure.html</guid>
    <pubDate>Wed, 15 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Financials</category>
    <description>Northrim BanCorp (NRIM) posted 2025 net income of roughly $64.6M versus $37M the year prior — a 75% step-up. The story is the Alaska deposit franchise that made it possible, and why the market still treats it as a sleepy community bank.</description>
  </item>
  <item>
    <title>Norwood Financial: steady, quiet, fine — and priced at exactly that</title>
    <link>https://microcapdesk.com/articles/norwood-financial-pennsylvania-deposit-base.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/norwood-financial-pennsylvania-deposit-base.html</guid>
    <pubDate>Wed, 15 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Financials</category>
    <description>Norwood Financial (NWFL) posted four consecutive quarters of net-interest-margin expansion and a mid-single-digit quarterly earnings trajectory. The Pennsylvania community bank is doing precisely what it is supposed to do. The market has already priced that in.</description>
  </item>
  <item>
    <title>SHF Holdings: cannabis-banking loan growth is the entire case</title>
    <link>https://microcapdesk.com/articles/shf-holdings-cannabis-banking-cash-runway.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/shf-holdings-cannabis-banking-cash-runway.html</guid>
    <pubDate>Wed, 15 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Financials</category>
    <description>SHF Holdings (SHFS) is the specialty banking platform for the state-legal cannabis industry. Quarterly loan-book growth is the only number that matters — and the trajectory continues to compound.</description>
  </item>
  <item>
    <title>AITX preliminary FY26: growth is real, the path to profitability still isn&#x27;t</title>
    <link>https://microcapdesk.com/articles/aitx-security-robot-deployments-cash-runway.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/aitx-security-robot-deployments-cash-runway.html</guid>
    <pubDate>Tue, 14 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Tech</category>
    <description>Artificial Intelligence Technology Solutions (AITX) posted 26% preliminary FY26 revenue growth above sector. RMR scale is finally at a point where gross-margin trajectory matters more than bookings headlines.</description>
  </item>
  <item>
    <title>Greene County Bancorp: boring compounders still compound</title>
    <link>https://microcapdesk.com/articles/greene-county-bancorp-deposit-franchise-thesis.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/greene-county-bancorp-deposit-franchise-thesis.html</guid>
    <pubDate>Tue, 14 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Financials</category>
    <description>Greene County Bancorp (GCBC) posted another quarter of EPS growth, consistent dividend policy, and disciplined asset quality. The unglamorous Hudson Valley community bank continues to do exactly what it has done for fifteen years.</description>
  </item>
  <item>
    <title>NN Inc raises guidance, and the grid/data-center mix is doing the work</title>
    <link>https://microcapdesk.com/articles/nn-inc-bearings-margin-recovery-thesis.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/nn-inc-bearings-margin-recovery-thesis.html</guid>
    <pubDate>Tue, 14 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Industrials</category>
    <description>NN Inc. (NNBR) raised guidance after $43M in new electric-grid and data-center program wins in Q1. The reposition away from automotive dependence is finally showing up in the mix.</description>
  </item>
  <item>
    <title>Theriva&#x27;s AACR data isn&#x27;t the story. The cash runway is.</title>
    <link>https://microcapdesk.com/articles/theriva-biologics-pancreatic-cancer-readout.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/theriva-biologics-pancreatic-cancer-readout.html</guid>
    <pubDate>Tue, 14 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Biotech</category>
    <description>Theriva Biologics (TOVX) presented VCN-01 in pancreatic cancer at AACR 2026. The 10-Q cash position against Phase 2b burn is what actually moves the equity.</description>
  </item>
  <item>
    <title>Gevo&#x27;s renewable jet fuel plant keeps the thesis alive — and the dilution question open</title>
    <link>https://microcapdesk.com/articles/gevo-renewable-jet-fuel-dilution-question.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/gevo-renewable-jet-fuel-dilution-question.html</guid>
    <pubDate>Mon, 13 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Energy</category>
    <description>Gevo (GEVO) Net-Zero 1 construction and Verity carbon-tracking commercialization are on track. The balance sheet to finish without another raise is the variable that decides the ending.</description>
  </item>
  <item>
    <title>Southern California Bancorp enters the Russell 2000 with the merger behind it</title>
    <link>https://microcapdesk.com/articles/southern-california-bancorp-merger-integration.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/southern-california-bancorp-merger-integration.html</guid>
    <pubDate>Sun, 12 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Financials</category>
    <description>Southern California Bancorp (BCAL) completed its merger of equals and is now included in the Russell 2000. Index inclusion plus merger accretion forces forward institutional buying. Setup is rare for small-cap banks.</description>
  </item>
  <item>
    <title>The boring biotech thesis: Biofrontera is actually selling things</title>
    <link>https://microcapdesk.com/articles/biofrontera-skin-cancer-treatment-reimbursement.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/biofrontera-skin-cancer-treatment-reimbursement.html</guid>
    <pubDate>Sun, 12 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Biotech</category>
    <description>Biofrontera (BFRI) has commercial dermatology revenue growing in the high teens against flat-to-down OpEx. The operating-leverage inflection arrived in Q1 2026. Not a story stock — which is the point.</description>
  </item>
  <item>
    <title>CEMATRIX&#x27;s foam-cement niche is actually a niche — which is the whole case</title>
    <link>https://microcapdesk.com/articles/civeo-canadian-oil-sands-lodging-recovery.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/civeo-canadian-oil-sands-lodging-recovery.html</guid>
    <pubDate>Sun, 12 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Industrials</category>
    <description>CEMATRIX (CVX.V) operates in the specialty foam-concrete category for infrastructure applications. Niche, but structural — and pricing power in niche concrete is more durable than the generalist infrastructure-supply thesis.</description>
  </item>
  <item>
    <title>New Horizon Aircraft: the eVTOL dilution cycle, continued</title>
    <link>https://microcapdesk.com/articles/hover-3d-property-data-construction-thesis.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/hover-3d-property-data-construction-thesis.html</guid>
    <pubDate>Sat, 11 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Tech</category>
    <description>New Horizon Aircraft (HOVR) continues the familiar eVTOL microcap playbook: ATM draws, reverse-split anniversary approaching, engineering milestones. At pre-revenue burn rates, the question is how many more times the share count doubles.</description>
  </item>
  <item>
    <title>Jaguar Health pivots to dogs. Whether it matters depends on the label.</title>
    <link>https://microcapdesk.com/articles/jaguar-health-canalevia-veterinary-thesis.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/jaguar-health-canalevia-veterinary-thesis.html</guid>
    <pubDate>Sat, 11 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Biotech</category>
    <description>Jaguar Health (JAGX) initiates canine chemotherapy-induced diarrhea trial for crofelemer. Human science ports cleanly. Veterinary monetization economics are a separate model entirely.</description>
  </item>
  <item>
    <title>LEEF Brands after the acquisition: the integration is the thesis now</title>
    <link>https://microcapdesk.com/articles/lifeway-foods-kefir-acquisition-pressure.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/lifeway-foods-kefir-acquisition-pressure.html</guid>
    <pubDate>Sat, 11 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Consumer</category>
    <description>LEEF Brands (LEEF.C) closed a material acquisition. The pre-deal thesis (&#x27;vertical California cannabis with clean unit economics&#x27;) becomes a new thesis (&#x27;can a small-cap actually integrate this cleanly&#x27;). Different question, same ticker.</description>
  </item>
  <item>
    <title>Kraken Robotics 2025 results: good year, richer multiple, fewer margin-of-safety yards</title>
    <link>https://microcapdesk.com/articles/kraken-robotics-underwater-defense-contracts.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/kraken-robotics-underwater-defense-contracts.html</guid>
    <pubDate>Fri, 10 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Industrials</category>
    <description>Kraken Robotics (KRKNF) delivered a clean 2025: revenue growth, profitability, expanded subsea order book. At current multiples relative to defense-tech peers, the thesis is high-quality but the margin of safety is thinner.</description>
  </item>
  <item>
    <title>U.S. Energy&#x27;s carbon-capture pivot is more interesting than the oil</title>
    <link>https://microcapdesk.com/articles/us-energy-carbon-capture-pivot-montana.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/us-energy-carbon-capture-pivot-montana.html</guid>
    <pubDate>Fri, 10 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Energy</category>
    <description>U.S. Energy Corp (USEG) is still running a small legacy E&amp;P business. The Montana helium-and-CO₂ project is the piece of the story with actual optionality — if the economics pencil.</description>
  </item>
  <item>
    <title>The Nightfood &quot;Foxconn deal&quot; demands a very close filing read</title>
    <link>https://microcapdesk.com/articles/nightfood-functional-snacks-distribution-thesis.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/nightfood-functional-snacks-distribution-thesis.html</guid>
    <pubDate>Thu, 09 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Industrials</category>
    <description>Nightfood Holdings (NGTF) announced a warehouse-robotics partnership framed with Foxconn branding. The 8-K and earlier filings describe a company whose track record does not comfortably support the headline narrative.</description>
  </item>
  <item>
    <title>Advantage Solutions and the delisting clock: when the floor is a compliance letter</title>
    <link>https://microcapdesk.com/articles/advantage-solutions-private-label-margin-thesis.html</link>
    <guid isPermaLink="true">https://microcapdesk.com/articles/advantage-solutions-private-label-margin-thesis.html</guid>
    <pubDate>Wed, 08 Apr 2026 00:00:00 +0000</pubDate>
    <dc:creator>The Desk</dc:creator>
    <category>Consumer</category>
    <description>Advantage Solutions (ADV) received a Nasdaq minimum-bid-price deficiency notice with a 180-day compliance period. The clock is now the dominant variable in the investment thesis.</description>
  </item>
</channel>
</rss>